NCT02234115 · MORE INFO

Limitations, agreements, and source contact

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma · Source last updated 2019-03-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

other Details: All information from the trial is property of the Sponsor and the PI has no right on it except the prior writing authorization of the sponsor.
pi Sponsor Employee: false
restriction Type: OTHER
restrictive Agreement: true

point Of Contact

Complete source fields

certain Agreement

other Details: All information from the trial is property of the Sponsor and the PI has no right on it except the prior writing authorization of the sponsor.
pi Sponsor Employee: false
restriction Type: OTHER
restrictive Agreement: true

point Of Contact

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice